Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Beam Therapeutics Inc (BEAM)

Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Beam Therapeutics Inc 238 Main Street Cambridge MA 02142 USA

https://beamtx.com Employees: 483 P: 857-327-8775

Sector:

Medical

Description:

Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 3,168,049
Enterprise Value, $K 2,886,079
Shares Outstanding, K 101,475
Float, K 97,923
% Float 96.50%
Short Interest, K 20,296
Short Float 20.00%
Days to Cover 15.66
Short Volume Ratio 0.53
% of Insider Shareholders 3.50%
% of Institutional Shareholders 99.68%

Financials:

Annual Sales, $ 63,520 K
Annual Net Income, $ -376,740 K
Last Quarter Sales, $ 9,700 K
Last Quarter Net Income, $ -112,730 K
EBIT, $ -466,290 K
EBITDA, $ -467,130 K

Growth:

1-Year Return 32.12%
3-Year Return -29.91%
5-Year Return -68.63%
5-Year Revenue Growth 317,500.00%
5-Year Earnings Growth 67.40%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.10 on 11/04/25
Next Earnings Date 02/24/26
Earnings Per Share ttm -4.43
EPS Growth vs. Prev Qtr -10.00%
EPS Growth vs. Prev Year 5.98%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 02/04/14
Dividend Payout Ratio 0.00%

BEAM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -42.86%
Return-on-Assets % -31.45%
Profit Margin % -593.10%
Debt/Equity 0.00
Price/Sales 52.62
Price/Cash Flow N/A
Price/Book 3.28
Book Value/Share 9.52
Interest Coverage -2.38
60-Month Beta 2.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar